Prot# CID 0910-Nucleosides and Inflammation, Coagulation and Endovascular Function The (NICE) Study. A Cross-Sectional Assessment of Markers Inflammation, Coagulation and Endothelial Function Among Patients Receiving Nucleoside Reverse Transcriptase Inhib

Project: Research project

Project Details

StatusFinished
Effective start/end date5/25/10 → 5/25/13

Funding

  • University of North Carolina at Chapel Hill (CID 0910 // CID 0910)
  • GlaxoSmithKline plc (CID 0910 // CID 0910)